JD vs LAB · P/E 7.6, rev $187.20B vs rev $174.4M
JD.com Inc Adr (JD) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
JD currently screens at market cap $45.56B and trailing P/E 7.6. LAB currently screens at market cap $317.1M.
Not investment advice. Open the JD and LAB stock pages for the full models.
Not investment advice.